Search results
31 sie 2015 · ACTH is a chemotherapy combination treatment used to treat HER2-positive breast cancer. It may also be called sequential AC/Taxol-Trastuzumab. The medicines in this combination are: Doxorubicin (Adriamycin), an anthracycline, and cyclophosphamide (Cytoxan), an alkylating agent, followed by treatment with
14 gru 2023 · This topic review will cover the use of adjuvant HER2-directed therapy plus chemotherapy in patients with HER2-positive, early-stage breast cancer (stage I to III).
8 paź 2021 · Though the efficacy of anthracycline chemotherapy is not debatable, potentially life-threatening and long-term risks accompany this class of agents, leading some to question their widespread...
31 lip 2017 · There was also a change in choice of chemotherapy during recent years — ACTH usage has dropped for this older population of patients with early-stage breast cancer, from 88% in 2005 to only 15%...
17 sie 2015 · Adjuvant cytotoxic chemotherapy regimens have evolved from single alkylating agents to polychemotherapy regimens incorporating anthracyclines and/or taxanes. This review summarizes key milestones in the evolution of adjuvant systemic therapy in general, and adjuvant chemotherapy in particular.
19 cze 2024 · With a primary endpoint of 5-year iDFS, the investigators were able to demonstrate considerable improvements to iDFS for those on a trastuzumab-containing regimen (AC-TH or TCH).
24 lut 2021 · The majority of the quality of life dimensions among Ethiopian breast cancer patients on AC and AC-T chemotherapy were significantly deteriorated clinically and statistically particularly during the first two cycles of chemotherapy despite its improvements afterward.
